Skip to main content

Sheets Smith Investment Management

SEC CIK
0001785199
Latest filing
Oct 8, 2025

HALO holding history

Halozyme Therapeutics, Inc. in every 13F filed by Sheets Smith Investment Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HALO overviewAll 13F holders of HALOFull Q3 2025 holdings

Shares (Q4 2022)
11,896
Value
$587.4K
% of portfolio
0.6%
Quarters held
2
Since Q2 2022
Holdings of HALO by Sheets Smith Investment Management, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 2023––––Not filedHolders
Q4 202211,896$587.4K0.6%–No prior filingHolders
Q3 2022––––Not filedHolders
Q2 202212,066$510.0K0.6%+12,066NewHolders